# Poonglim Pharmatech to build fourth plant in Saemangeum, South Korea

Poonglim Pharmatech signed an investment agreement on January 26, 2022, to build a fourth plant in the Saemangeum National Industrial Complex, investing 19.5 billion won on a 13,200 m² site. Construction will start in June 2022, with completion by 2024, creating 70 new jobs.

- Type: New facility
- Announced: 2022-01-26
- Where: Saemangeum National Industrial Complex, Gunsan, North Jeolla Province, South Korea
- Value: $16.3M (19.5B KRW)
- Jobs: 70
- Starts operating: 2024
- Status: announced
- Products: ophthalmic and joint preparations, hyaluronic acid and collagen osteoarthritis treatments, diagnostic medical devices
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Poonglim Pharmatech](https://endata.com/companies/32343.md)

## Sources

- [news.nate.com](https://news.nate.com/view/20220127n00536), 2022-01-27: "업체는 오는 6월 새만금 산단 부지 1만3200㎡에 195억원을 투자해 제4공장을 착공해 2024년까지 신규 직원 70명을 채용할 계획이다."
- [investkorea.org](https://www.investkorea.org/jnbk-en/bbs/i-1334/detail.do?ntt_sn=491251), 2022-02-08: "Poonglim Pharmatech signed an investment agreement for construction of 'medicine and medical device manufacturing facility' with Jeollabuk-do, Gunsan-si, Saemangeum Development and Investment Agency, and the Korea Rural Community Corporation on February 26."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.